Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al

Ann Rheum Dis. 2021 May;80(5):e66. doi: 10.1136/annrheumdis-2020-218193. Epub 2020 Jun 25.

Authors

Emanuele Bozzalla Cassione^{1

2}, Giovanni Zanframundo^{1

2}, Alessandro Biglia^{1

2}, Veronica Codullo¹, Carlomaurizio Montecucco^{3

2}, Lorenzo Cavagna^{1

2}

Affiliations

¹ Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.
² Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.
³ Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy montecucco@smatteo.pv.it.

PMID: 32586917
DOI: 10.1136/annrheumdis-2020-218193

No abstract available

Keywords: arthritis; health services research; lupus erythematosus; rheumatoid; scleroderma; systemic.

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / epidemiology
COVID-19*
Humans
Pandemics
SARS-CoV-2
Telemedicine*